Lumbar spinal stenosis, lumbar disc herniation, lumbar spondylolisthesis
Conditions
Interventions
D:20mg/Kg intravenous TXA at 5 minutes before cutting the skin, and 10mg/Kg intravenous TXA at 3h, 6h, 12h and 24h respectively
E:40mg/Kg intravenous TXA at 5 minutes before cutting the skin, and 10mg/Kg intravenous TXA at 3h, 6h, 12h and 24h respectively
F:60mg/Kg intravenous TXA at 5 minutes before cutting the skin, and 10mg/Kg intravenous TXA at 3h, 6h, 12h and 24h respectively
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Patients who need surgery for spinal diseases such as lumbar spinal stenosis, lumbar disc herniation, and lumbar spondylolisthesis; (2) Normal platelet and coagulation function preoperatively; (3) Normal intravenous ultrasound in the lower extremities preoperatively; (4) To be able to and willing to provide signed informed consent
Exclusion criteria
Exclusion criteria: (1) Systemic infections such as pulmonary infection or urinary tract infection are not controlled preoperatively; (2) Abnormal immune function or combined immune-related disease preoperatively; (3) Abnormal inflammatory index preoperatively (C-reactive protein >20 mg/L); (4) Abnormal fibrinolysis index preoperatively (FDP > 5mg/L); (5) Discontinuation of oral anticoagulants or aspirin less than 1 week; (6) Allergy to tranexamic acid (TXA) or dexamethasone or have contraindications; (7) Patients at high risk of thrombosis; (8) History of deep vein thrombosis (VTE, calf muscle vein thrombosis or superficial vein thrombosis, pulmonary embolism); (9) Serious liver and kidney dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss;Surgical field definition;Hb;ESR, CRP, IL-6, IL-10;perioperative complications: deep vein thrombosis; | — |
Countries
China
Contacts
Public ContactQingquan Kong
Department of Orthopedics Surgery, West China Hospital, Sichuan University
Outcome results
None listed